Status:
WITHDRAWN
Minimally-invasive Assessment of Cardiac Output in Severe Preeclampsia
Lead Sponsor:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Conditions:
Preeclampsia
Eligibility:
FEMALE
18+ years
Brief Summary
Severe preeclampsia often presents with uncontrolled hypertension and therefore requires close monitoring of blood pressure and cardiac performance. The purpose of the study is to compare two methods...
Detailed Description
Severe preeclampsia often presents with uncontrolled hypertension, which requires close monitoring of blood pressure and cardiac output. It will be very useful to know the cardiac output in this patie...
Eligibility Criteria
Inclusion
- Severe Preeclampsia
- Arterial Line Required
- Candidates for magnesium sulfate, labetalol or hydrazine
Exclusion
- Preexisting cardiac disease
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00465114
Start Date
April 1 2007
End Date
December 1 2007
Last Update
February 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5